Caregivers who had less than a high school education (compared to a master’s degree or higher) had more challenges accessing COVID-19 tests, lower odds of working remotely (adjusted odds ratio [aOR], 0.04; 95% confidence interval [CI], 0.03 to 0.07), and more food-access concerns (aOR, 4.14; 95% CI, 3.20 to 5.36).
The updated COVID-19 booster shots were designed to target the XBB variant, and they’ll still likely work just as well against the new dominant strain.
A new Covid-19 variant has become the dominant lineage of the virus in recent weeks in the US and while it should not be a cause of undue concern for the public, its emergence is a reminder of the need for greater surveillance of the virus and of the importance of vaccine boosters, according to infectious disease experts.
A new real-world study in Greece finds that for high-risk patients, COVID-19 antivirals are highly effective in reducing the risk of both hospitalization and death. The study is published in The Journal of Infectious Diseases.
Patients who were older than 75, and reported good drug adherence benefitted the most from the drugs molnupiravir (Lagevrio) and nirmatrelvir/ritonavir (Paxlovid)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/KQY6Q2HQGROSVPRNTFTB2D3LJU.jpg)
